Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606
Clinical trial NCT04041648 · COMPLETED
Trial details
- NCT number
- NCT04041648
- Sponsor
- Pharmosa Biopharm Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-09
- Primary completion
- 2019-09-20
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.